Newer antipsychotics

被引：8

作者：

Marder, SR

机构：

[1] Vet Affairs Greater Los Angeles Hlth Care Syst, W Los Angeles Hlth Ctr, Desert Pacific Mental Illness Res Educ & Clin Ctr, Los Angeles, CA USA

[2] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA

来源：

CURRENT OPINION IN PSYCHIATRY | 2000年 / 13卷 / 01期

关键词：

D O I：

10.1097/00001504-200001000-00003

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Newer antipsychotics have been widely used in schizophrenia for the past 5 years. During this period, controlled clinical trials have improved our understanding of the effectiveness of these agents in different populations of patients with schizophrenia. Other studies have enhanced our understanding of how improvement on these agents is associated with the occupancy of central nervous system receptors, The best understood of the newer agents is clozapine, although clinically important information has become available for risperidone, olanzapine, quetiapine and amisulpride. Curr Opin Psychiatry 13:11-14. (C) 2000 Lippincott Williams & Wilkins.

引用

页码：11 / 14

页数：4

共 17 条

[1] Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
Breier, A
Hamilton, SH
[J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (04) : 403 - 411
[2] Breier AF, 1999, AM J PSYCHIAT, V156, P294
[3] Buchanan RW, 1998, AM J PSYCHIAT, V155, P751
[4] Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
Conley, RR
Tamminga, CA
Bartko, JJ
Richardson, C
Peszke, M
Lingle, J
Hegerty, J
Love, R
Gounaris, C
Zaremba, S
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (07) : 914 - 920
[5] Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine
Conley, RR
Love, RC
Kelly, DL
Bartko, JJ
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06) : 863 - 868
[6] Danion JM, 1999, AM J PSYCHIAT, V156, P610
[7] Kapur S, 1999, AM J PSYCHIAT, V156, P286
[8] Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients
Kern, RS
Green, MF
Marshall, BD
Wirshing, WC
Wirshing, D
McGurk, S
Marder, SR
Mintz, J
[J]. BIOLOGICAL PSYCHIATRY, 1998, 44 (08) : 726 - 732
[9] Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
Leucht, S
Pitschel-Walz, G
Abraham, D
Kissling, W
[J]. SCHIZOPHRENIA RESEARCH, 1999, 35 (01) : 51 - 68
[10] Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients
Nyberg, S
Eriksson, B
Oxenstierna, G
Halldin, C
Farde, L
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06) : 869 - 875

← 1 2 →